The Pfizer-BioNTech COVID-19 vaccine is associated with a lower risk of developing myocarditis, pericarditis or myopericarditis than the Moderna Spikevax…

The immediate use of extracorporeal membrane oxygenation (ECMO) devices is not associated with improved outcomes for patients who present with cardiogenic shock (CS), according to new findings presented at the…

Artificial intelligence (AI) has the potential to be a true game-changer for patient care—but it can only reach that potential if physicians and other…

Electrocardiograms (ECGs) of the first patient to receive a genetically modified pig heart revealed some surprising findings, according to…

Abiomed’s…

Dapagliflozin (Farxiga) is associated with consistent benefits for patients with heart failure with mildly reduced ejection…

The U.S. Food and Drug Administration (FDA) has been as busy as ever in October, making…

Researchers from a variety of schools—including the VCU School of Medicine, Baylor College of Medicine and University of…

Children between the ages of 12 and 15 face very low risk of developing myocarditis after being vaccinated for COVID-19, according to new research published in…

Patients are seven times more likely to develop myocarditis after a COVID-19 infection than after receiving a COVID-19 vaccine, according to a new meta-analysis…

Deaths related to heart failure (HF) are becoming more and more common in the United States, according to a new study published in JACC: Heart Failure…

Wake Forest University School of Medicine has received a five-year grant worth $30 million from the National Institute of Aging, part of the National…

As transcatheter aortic valve replacement (TAVR) continues to gain momentum as a go-to treatment option for a wide range of patients with…

Abiomed’s Impella heart pumps are associated with improved 30-day survival rates for cardiogenic shock patients, according to two new studies presented at Transcatheter Cardiovascular Therapeutics (TCT…

The American Hospital Association (AHA) and the American Medical Association (AMA) have dropped their legal challenge to the interim…

Moderate-to-severe and severe mitral regurgitation (MR) are significantly associated with a heightened risk of death among older patients with heart failure…

Cardiologists in Portugal treated a 31-year-old monkeypox patient who went on to develop acute myocarditis shortly after the onset of symptoms. The group shared its story in JACC: Case Reports.[1]

…

The U.S. Food and Drug Administration (FDA) has announced another recall related to Medtronic’s HeartWare Ventricular Assist Device (HVAD). This is a Class I recall, which means using the device in…

Patients face a much higher risk of myocarditis after a COVID-19 infection than after receiving a COVID-19 vaccine, according to new research published in …

Patients with type 2 diabetes (T2D) who take non-steroidal anti-inflammatory drugs (NSAIDs) may face an increased risk of heart failure, according to new…

The National Heart, Lung, and Blood Institute—part of the National Institutes of Health—has awarded an $11.2 million grant to researchers who will investigate,…